First Header Logo Second Header Logo

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.

Choi AR, D'Agostino RB, Farris MK, Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Ruiz J, Lycan TW, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Li W, Su J, Whitlow C, Xing F, Chan MD. Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne). 2024; 15:1364021.

View in: PubMed